Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
0.3923
-0.0237 (-5.70%)
At close: Mar 26, 2026, 4:00 PM EDT
0.3816
-0.0107 (-2.73%)
Pre-market: Mar 27, 2026, 8:06 AM EDT

Jaguar Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
111441732
Market Cap Growth
-81.25%183.90%-11.81%-75.94%-44.61%733.36%
Enterprise Value
29.8440.4433.9232.3929.7939.66
Last Close Price
0.3925.2575.753258.7539000.0091696.75
PE Ratio
--0.19-0.03-0.06-0.29-0.27
PS Ratio
0.120.900.380.354.033.36
PB Ratio
0.461.440.75-6.401.501.83
P/TBV Ratio
10.981.020.24-4.34--
P/FCF Ratio
--0.36-0.11-0.13-0.51-2.06
P/OCF Ratio
--0.36-0.11-0.13-0.51-2.06
EV/Sales Ratio
2.533.463.482.716.874.23
EV/EBITDA Ratio
--1.40-1.05-1.00-0.76-1.59
EV/EBIT Ratio
--1.31-0.99-0.94-0.73-1.49
EV/FCF Ratio
--1.38-1.02-0.98-0.87-2.59
Debt / Equity Ratio
7.274.037.50-25.332.460.94
Debt / EBITDA Ratio
-1.03-1.26-1.15-1.07-0.75-0.65
Debt / FCF Ratio
-1.23-1.24-1.11-1.05-0.85-1.06
Net Debt / Equity Ratio
5.043.926.17-44.701.060.47
Net Debt / EBITDA Ratio
-0.92-0.99-0.95-0.90-0.32-0.33
Net Debt / FCF Ratio
-1.09-0.97-0.92-0.88-0.36-0.53
Asset Turnover
0.230.220.200.240.090.24
Inventory Turnover
0.200.200.250.340.611.34
Quick Ratio
0.140.490.620.261.240.96
Current Ratio
0.811.632.000.741.841.35
Return on Equity (ROE)
-615.35%-565.74%-2366.62%-922.07%-362.07%-179.03%
Return on Assets (ROA)
-63.80%-59.18%-69.83%-68.34%-84.71%-67.25%
Return on Invested Capital (ROIC)
-91.74%-83.61%-107.95%-131.91%-163.92%-106.29%
Return on Capital Employed (ROCE)
-139.46%-87.47%-127.27%-125.36%-120.76%-105.24%
Earnings Yield
-2749.30%-517.58%-3535.54%-1665.36%-339.31%-368.06%
FCF Yield
-1779.37%-279.18%-897.08%-789.31%-196.75%-48.46%
Buyback Yield / Dilution
-671.64%-1809.95%-1663.72%---
Total Shareholder Return
-671.64%-1809.95%-1663.72%---
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q